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Key Clinical Message
Although use of electronic nicotine delivery system devices, such as e-cigarettes
and vapor pens, is on the rise, no treatment protocols exist to help such users
quit. We report the case of a 24-year-old patient in a tobacco treatment
program who successfully quit e-cigarette use by using nicotine replacement
therapy.
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Background
The prevalence of electronic nicotine delivery systems
(ENDS), such as e-cigarettes and vapor pens, is on the
rise around the world [1]. While e-cigarettes may have
potential roles in assisting with smoking cessation or
tobacco harm reduction [2], they are not currently
approved or regulated by the Food and Drug Administra-
tion. Although several studies show that use of e-cigar-
ettes is associated with initial reduction in tobacco use
[2–4], their safety and long-term efficacy as cessation
devices are unknown [4]. The majority of people who use
e-cigarettes formerly smoked tobacco cigarettes [5], and
many continue to smoke cigarettes while also using ENDS
[5], a phenomenon referred to as dual use. The preva-
lence of dual use suggests that regular e-cigarette use may
promote continued tobacco addiction, especially since
most of the psychological aspects of cigarette addiction
are also operative with e-cigarettes and other ENDS [6].
The potentially addictive nature of e-cigarettes has
received little attention in the research literature, and
providers who want to help ENDS users discontinue use
of these devices need guidance on evidence-based meth-
ods. The current report presents the case of an individual
who had used an e-cigarette to assist in quitting smoking
but found that he was unable to stop e-cigarette use; he
entered our program to quit using e-cigarettes. With a
combination of behavioral counseling and nicotine
replacement therapy (NRT), he became completely
tobacco free.
Case Presentation
A 24-year-old Caucasian male enrolled in a tobacco treat-
ment program with the stated desire to cease using e-
cigarettes. He described concerns about his health and fit-
ting in with his social circle, in which smoking and vap-
ing (inhaling vapor from e-cigarettes) were not
acceptable. He began “experimenting with cigarettes”
around age 17 and smoked 20 cigarettes per day until he
was 19, when he quit for 1 year. He resumed smoking at
age 20 and then quit for another year at age 22, before
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resuming smoking at age 23. He had not used tobacco
cessation medications during either of these periods of
abstinence from smoking. After starting to smoke tobacco
cigarettes again, he began using the e-cigarette at age 24,
thinking that this would be a good step toward perma-
nent cessation. He liked the hand-to-mouth activity of
both smoking and vaping and felt that vaping helped him
relieve work-related stress in the same way that cigarettes
did. He started vaping within 30 min of waking and
vaped up to 10 times a day, averaging one 16 mg bottle
of liquid nicotine per week. By the time he entered the
tobacco treatment program, he had quit smoking tobacco
cigarettes and had been vaping for approximately
7 months.
Treatment
The tobacco treatment specialist (TTS) used three indica-
tors, based on the Fagerstr€om scale for nicotine depen-
dence [7], to estimate his e-cigarette dependence level as
moderate: number of cigarettes smoked per day (approxi-
mately 20) when he smoked tobacco cigarettes, time to
first e-cigarette (30 min), and smoking while ill. The TTS
initially recommended the daily use of a 14 mg patch,
supplemented with 4 mg nicotine lozenges, which he used
approximately eight times per day, combined with strate-
gies for behavioral change. After the first week of using
both, he reported that he cut his e-cigarette use in half.
He discontinued the patch after 1 week because he felt he
had no control over its dosing. He continued to use
approximately eight nicotine lozenges (4 mg) per day,
and he reported 2 days without vaping in weeks 3 and 4.
Six weeks into the program, he asked to try 4 mg cinna-
mon nicotine gum, as cinnamon was his preferred e-
cigarette flavor, and he thought the flavor similarity
might help him reach his goal. His intuition proved to be
correct; before completion of the 12-week program, he
had quit using the e-cigarette entirely. He used the NRT
intermittently for the next 6 months, at which time he
discontinued use. More than a year after quitting e-cigar-
ettes, he remains e-cigarette, tobacco, and nicotine free.
Discussion
We believe this is the first case reported in the literature
of successful abstinence from e-cigarette dependence
achieved using recommended evidence-based treatment
for tobacco use and dependence [8]. Multiple elements of
this report are unique. First, no reliable measure similar
to the Fagerstr€om scale for tobacco cigarette dependence
exists to assess dependence levels for e-cigarette or dual
users. As dual use becomes more prevalent [9], clinicians
must have objective guidelines to assess dependence levels
and ascertain appropriate treatment options for such
users.
In addition, because no literature exists about using
NRT to discontinue ENDS use, one of the biggest chal-
lenges involves estimating the equivalent amount of NRT
to recommend [10]. NRT works because the patient
receives nicotine in an effective, safer, and less addictive
form than in cigarettes [11]. This allows the patient to
slowly wean off of nicotine. In contrast, ENDS product
labels can be misleading, especially with “do-it-yourself”
refills [12], and patients’ reports on quantity of nicotine
consumption may be inaccurate. Thus, determining
appropriate treatment protocols for patients who wish to
quit using ENDS can be challenging. At the least, clini-
cians will need to monitor and quantify, as best as possi-
ble, both NRT and any continued ENDS use in order to
refine treatment recommendations. Further research and
improved protocols are needed to help determine the
translation of ENDS use to nicotine absorption.
The effects of flavorings in NRT, and their relationship
with flavors the individual might have used in ENDS, also
merit further study. In this case, the cinnamon nicotine
replacement flavoring – and the ability of the patient to
adjust the dose himself – assisted his attempts to quit and
led to optimal dosing. The similarity of flavor of the nico-
tine gum to an e-cigarette flavor that the patient enjoyed
helped him be more open to using the gum and may aid
others in cessation from e-cigarettes, the majority of
which are flavored.
As ENDS and dual use increases, clinicians need clearer
guidelines to assist those who wish to quit. These guideli-
nes should include protocols for assessing dependence
levels and for recommending treatment options, which
could include NRT, other pharmaceutical aids, and
behavioral therapy. Such guidelines are necessary to





1. Pepper, J. K., and N. T. Brewer. 2014. Electronic nicotine
delivery system (electronic cigarette) awareness, use,
reactions and beliefs: a systematic review. Tob. Control
23:375–384.
2. Rahman, M. A., N. Hann, A. Wilson, G. Mnatzaganian,
and L. Worrall-Carter. 2015. E-cigarettes and smoking
cessation: evidence from a systematic review and meta-
analysis. PLoS One 10:e0122544.
3. Polosa, R., P. Caponnetto, J. B. Morjaria, G. Papale, D.
Campagna, and C. Russo. 2011. Effect of an electronic
410 ª 2016 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
NRT to Quit E-Cigarettes B. Silver et al.
nicotine delivery device (e-Cigarette) on smoking
reduction and cessation: a prospective 6-month pilot
study. BMC Public Health 11:786.
4. Brose, L. S., S. C. Hitchman, J. Brown, R. West, and A.
McNeill. 2015. Is the use of electronic cigarettes while
smoking associated with smoking cessation attempts,
cessation and reduced cigarette consumption? A survey
with a 1-year follow-up. Addiction 110:1160–1168.
5. Etter, J.-F., and C. Bullen. 2011. Electronic cigarette: users
profile, utilization, satisfaction and perceived efficacy.
Addiction 106:2017–2028.
6. Bell, K., and H. Keane. 2012. Nicotine control: e-cigarettes,
smoking and addiction. Int. J. Drug Policy 23:242–247.
7. Heatherton, T. F., L. T. Kozlowski, R. C. Frecker, and
K.-O. Fagerstrom. 1991. The Fagerstr€om test for nicotine
dependence: a revision of the Fagerstrom Tolerance
Questionnaire. Br. J. Addict. 86:1119–1127.
8. Fiore, M. 2008. Treating tobacco use and dependence:





(accessed January 28, 2015).
9. Soneji, S., J. Sargent, and S. Tanski. 2016. Multiple tobacco
product use among US adolescents and young adults. Tob.
Control 25:174–180.
10. Westenberger, B. J. 2009. US Food and Drug
Administration evaluation of e-cigarettes, Vol. 200. Center
for Drug Evaluation and Research, Division of
Pharmaceutical Analysis, US Food and Drug
Administration, Rockville, MD. available at: http://
www.fda.gov/downloads/drugs/scienceresearch/
ucm173250.pdf
11. Commissioner O of the. Consumer Updates – FDA 101:
Smoking Cessation Products. http://www.fda.gov/
ForConsumers/ConsumerUpdates/ucm198176.htm
(accessed May 26, 2015).
12. Davis, B., M. Dang, J. Kim, and P. Talbot. 2015. Nicotine
concentrations in electronic cigarette refill and do-it-
yourself fluids. Nicotine Tob. Res. 17:134–141.
ª 2016 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. 411
B. Silver et al. NRT to Quit E-Cigarettes
